Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,074 | 32,109 | 111,973 | 183,467 | 486,620 |
| Marketable Securities | 248,444 | 264,316 | 143,705 | 141,815 | 26,573 |
| Receivables | 5,338 | 0 | N/A | N/A | N/A |
| TOTAL | $309,888 | $306,519 | $261,880 | $331,780 | $522,322 |
| Non-Current Assets | |||||
| PPE Net | 10 | 1,648 | 3,981 | 5,320 | 5,534 |
| Other Non-Current Assets | 5,394 | 3,749 | 6,589 | 6,557 | 11,577 |
| TOTAL | $5,404 | $5,397 | $10,570 | $11,877 | $17,111 |
| Total Assets | $315,292 | $311,916 | $272,450 | $343,657 | $539,433 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 11,613 | 11,613 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,319 | 5,526 | 1,459 | 3,244 | 7,508 |
| Accrued Expenses | 25,641 | 34,459 | 36,158 | 36,615 | 31,142 |
| Other current liabilities | 17,050 | 0 | N/A | N/A | N/A |
| TOTAL | $45,010 | $51,598 | $49,230 | $39,859 | $38,650 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 814 | 11,988 | 29,079 | 28,744 |
| Other Non-Current Liabilities | 240,790 | 196,735 | 199,155 | 153,256 | 151,355 |
| TOTAL | $240,790 | $197,549 | $211,143 | $182,335 | $180,099 |
| Total Liabilities | $285,800 | $249,147 | $260,373 | $222,194 | $218,749 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 227,221 | 225,582 | 94,985 | 76,477 | 75,528 |
| Common Shares | 23 | 23 | 10 | 8 | 8 |
| Retained earnings | -1,268,568 | -1,212,040 | -1,032,223 | -811,534 | -577,530 |
| Other shareholders' equity | 1,189 | -350 | -574 | 45 | 599 |
| TOTAL | $29,492 | $62,769 | $12,077 | $121,463 | $320,684 |
| Total Liabilities And Equity | $315,292 | $311,916 | $272,450 | $343,657 | $539,433 |